Literature DB >> 18776644

Methylation status of CpG islands at sites -59 to +96 in exon 1 of the BRCA2 gene varies in mammary tissue among women with sporadic breast cancer.

Nurhan Cucer1, Serpil Taheri, Engin Ok, Yusuf Ozkul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18776644     DOI： 10.1007/s12041-008-0023-5

Source DB:  PubMed          Journal:  J Genet        ISSN： 0022-1333            Impact factor:   1.166


× No keyword cloud information.
  25 in total

1.  Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.

Authors:  E Gras; J Cortes; O Diez; C Alonso; X Matias-Guiu; M Baiget; J Prat
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

2.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

3.  Somatic mutations in the neurofibromatosis 1 gene in human tumors.

Authors:  Y Li; G Bollag; R Clark; J Stevens; L Conroy; D Fults; K Ward; E Friedman; W Samowitz; M Robertson
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

4.  Mutations of the BRCA2 gene in ovarian carcinomas.

Authors:  H Takahashi; H C Chiu; C A Bandera; K Behbakht; P C Liu; F J Couch; B L Weber; V A LiVolsi; M Furusato; B A Rebane; A Cardonick; I Benjamin; M A Morgan; S A King; J J Mikuta; S C Rubin; J Boyd
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

5.  Quantitative assessment of promoter hypermethylation during breast cancer development.

Authors:  Ulrich Lehmann; Florian Länger; Henning Feist; Sabine Glöckner; Britta Hasemeier; Hans Kreipe
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

6.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.

Authors:  M Gonzalez-Zulueta; C M Bender; A S Yang; T Nguyen; R W Beart; J M Van Tornout; P A Jones
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

7.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

Authors:  J G Herman; A Merlo; L Mao; R G Lapidus; J P Issa; N E Davidson; D Sidransky; S B Baylin
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

Review 8.  Structural insights into BRCA2 function.

Authors:  Yousif Shamoo
Journal:  Curr Opin Struct Biol       Date:  2003-04       Impact factor: 6.809

9.  Structural rearrangement of the retinoblastoma gene in human breast carcinoma.

Authors:  A T'Ang; J M Varley; S Chakraborty; A L Murphree; Y K Fung
Journal:  Science       Date:  1988-10-14       Impact factor: 47.728

10.  CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.

Authors:  Varinderpal S Dhillon; Mohd Shahid; Syed Akhtar Husain
Journal:  Mol Cancer       Date:  2004-12-01       Impact factor: 27.401
View more
  3 in total

Review 1.  Fanconi anaemia: from a monogenic disease to sporadic cancer.

Authors:  Antonio Valeri; Sandra Martínez; José A Casado; Juan A Bueren
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

2.  Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology.

Authors:  Ranjana Pal; Niloo Srivastava; Rupali Chopra; Sailesh Gochhait; Pawan Gupta; Neeraj Prakash; Gaurav Agarwal; Rameshwar N K Bamezai
Journal:  Mol Cancer       Date:  2010-11-23       Impact factor: 27.401

3.  Aberrant DNA methylation of cancer-related genes in giant breast fibroadenoma: a case report.

Authors:  Diego M Marzese; Francisco E Gago; Javier I Orozco; Olga M Tello; María Roqué; Laura M Vargas-Roig
Journal:  J Med Case Rep       Date:  2011-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.